Market Overview

Acorda Therapeutics Jumping On Takeover Rumors


Acorda Therapeutics Inc. (NASDAQ: ACOR) shares are jumping after news hit the wires that Biogen Idec (NASDAQ: BIIB) may be looking for a partner in multiple sclerosis drugs.

At last check, shares of Acorda Therapeutics were up $1.06 to $31.94, a gain of around 3%.

Posted-In: News Rumors M&A


Related Articles (ACOR + BIIB)

View Comments and Join the Discussion!

Partner Center